EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance

María Gordillo-Marañón, Agnieszka Szmigiel, Vladimíra Yalmanová, Irina Caplanusi, Georgy Genov, David Benee Olsen, Sabine Straus

Drug Safety · 2024-08 · 47 (8) · 783-798

DOI: 10.1007/s40264-024-01426-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, online erschienen am 12.04.2024. Verfasst von María Gordillo-Marañón und 6 weiteren Autor:innen. Beteiligte Einrichtung: Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, COVID-19, COVID-19 Vaccines, Menorrhagia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsCOVID-19COVID-19 VaccinesMenorrhagiaFemaleHumansDatabases, FactualEuropean UnionMass MediaPharmacovigilance

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands.
  • Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, UK.
  • Pharmacovigilance Office, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands. agnieszka.szmigiel@ema.europa.eu.
  • Stakeholders and Communication, European Medicines Agency, Amsterdam, The Netherlands.
  • Pharmacovigilance Office, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands.
  • Department of Pharmacovigilance, Norwegian Medical Products Agency, Oslo, Norway.

Zitieren

APA

Gordillo-Marañón, M., Szmigiel, A., Yalmanová, V., Caplanusi, I., Genov, G., Olsen, D. B., & Straus, S. (2024). COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance. Drug Safety, 47(8), 783-798. https://doi.org/10.1007/s40264-024-01426-4

Vancouver

Gordillo-Marañón M, Szmigiel A, Yalmanová V, Caplanusi I, Genov G, Olsen DB, et al. COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance. Drug Safety. 2024;47(8):783-798. doi:10.1007/s40264-024-01426-4

BibTeX
@article{GordilloMaran2024,
  author = {Gordillo-Marañón, María and Szmigiel, Agnieszka and Yalmanová, Vladimíra and Caplanusi, Irina and Genov, Georgy and Olsen, David Benee and Straus, Sabine},
  title = {COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance},
  journal = {Drug Safety},
  year = {2024},
  volume = {47},
  number = {8},
  pages = {783--798},
  doi = {10.1007/s40264-024-01426-4}
}
Kostenlos starten →